InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: bwolfy2002 post# 154838

Thursday, 03/25/2021 6:40:04 PM

Thursday, March 25, 2021 6:40:04 PM

Post# of 233144

If you’re going to go that route, then we’ll need to wait until cd16/17 are done given that’s essentially a new endpoint; like everyone else does mid-trial.


Leron has failed both of its trials. Lenz hasn't failed any trial. The results of leron's trials don't give much hope than their next trial will succeed. They had to look at a subgroup that represented less than 20% of the trial's patients and in that small subgroup the treatment arm had 38% mortality and the placebo arm had 47% mortality. Weak sauce. And that is the best cherry they could find to pick. HGEN, on the other hand, is a GM-CSF inhibitor and it has been shown that GM-CSF is the cause of severe Covid and death.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News